Diamedica Therapeutics Inc (DMAC)
$9.25 -2.84% Close Oct 30, 2026 Live
Diamedica Therapeutics stock today
Diamedica Therapeutics closed at $9.25 on October 30, 2026, down 2.84% on the day. Over the past year it returned +32.1% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $498 million.
$6.00$8.00$10.00
NovJan 2026MarMayJulSep
| Period | DMAC | S&P 500 (SPY) |
|---|---|---|
| 1 month | +11.9% | -0.9% |
| 3 months | +42.1% | +2.1% |
| Year to date | +16.2% | +11.7% |
| 1 year | +32.1% | +12.4% |
| 3 years | +330.2% | +88.5% |
| 5 years | +134.2% | +76.0% |
Key statistics
- Market value
- $498M
- 52-week range
- $5.33 to $9.82
- Next report
- Nov 11, 2026 (estimated)
About Diamedica Therapeutics
Biopharmaceutical company developing therapeutic treatments for neurological and other diseases.
Sector: Health Care
More on Diamedica Therapeutics
- Returns: what $1,000 became$1,000 ten years ago is $2,345 today
No forecast, no recommendation. This page describes Diamedica Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.